chr15-63326051-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001218.5(CA12):c.*234C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0542 in 554,132 control chromosomes in the GnomAD database, including 1,029 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.045 ( 198 hom., cov: 32)
Exomes 𝑓: 0.058 ( 831 hom. )
Consequence
CA12
NM_001218.5 3_prime_UTR
NM_001218.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.620
Genes affected
CA12 (HGNC:1371): (carbonic anhydrase 12) Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. This gene product is a type I membrane protein that is highly expressed in normal tissues, such as kidney, colon and pancreas, and has been found to be overexpressed in 10% of clear cell renal carcinomas. Three transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 15-63326051-G-A is Benign according to our data. Variant chr15-63326051-G-A is described in ClinVar as [Benign]. Clinvar id is 1291975.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0615 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CA12 | NM_001218.5 | c.*234C>T | 3_prime_UTR_variant | 11/11 | ENST00000178638.8 | ||
LOC124903506 | XR_007064676.1 | n.767+7297G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CA12 | ENST00000178638.8 | c.*234C>T | 3_prime_UTR_variant | 11/11 | 1 | NM_001218.5 | A1 | ||
CA12 | ENST00000344366.7 | c.*234C>T | 3_prime_UTR_variant | 10/10 | 1 | P4 | |||
CA12 | ENST00000422263.2 | c.*234C>T | 3_prime_UTR_variant | 9/9 | 2 | ||||
CA12 | ENST00000560666.1 | n.509C>T | non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0448 AC: 6821AN: 152184Hom.: 198 Cov.: 32
GnomAD3 genomes
AF:
AC:
6821
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0578 AC: 23229AN: 401830Hom.: 831 Cov.: 0 AF XY: 0.0588 AC XY: 12510AN XY: 212654
GnomAD4 exome
AF:
AC:
23229
AN:
401830
Hom.:
Cov.:
0
AF XY:
AC XY:
12510
AN XY:
212654
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0448 AC: 6823AN: 152302Hom.: 198 Cov.: 32 AF XY: 0.0441 AC XY: 3284AN XY: 74466
GnomAD4 genome
AF:
AC:
6823
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
3284
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
126
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at